Hasan, M K
Yu, J
Chen, L
Cui, Bing
Widhopf II, G F
Rassenti, L
Shen, Z
Briggs, S P
Kipps, T J
Article History
Received: 21 December 2016
Revised: 24 February 2017
Accepted: 17 March 2017
First Online: 3 May 2017
Competing interests
: Cirmtuzumab was developed in the Kipps laboratory and licensed by Oncternal Therapeutics, Inc. from the University of California, San Diego.